US Patent Issued to ACUPATH LABORATORIES on June 16 for "Use of artificial intelligence ("AI") to detect the expression of Cytokeratin 17 in urothelial cells from patients' voided urine" (New York Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,657,713, issued on June 16, was assigned to ACUPATH LABORATORIES INC. (Plainview, N.Y.).

"Use of artificial intelligence ("AI") to detect the expression of Cytokeratin 17 in urothelial cells from patients' voided urine" was invented by Michael Matthews (Baldwin, N.Y.), Brian Kunkel (Huntington, N.Y.), John Cucci (Saint James, N.Y.) and Thomas M. Dewar (Yonkers, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Conventional, manual identification and scoring of a whole slide image (WSI) to detect Cytokeratin 17 (K17) expression has limitations in terms of lower accuracy in the medium grade cases, slower turn-around time, and high inter and intra-observ...